Take The Stress Out of Pediatric Hypertension! Rasheda Amin, MD Division of Nephrology Pediatric Specialists of Virginia George Washington University
|
|
- Polly Stephens
- 5 years ago
- Views:
Transcription
1 Take The Stress Out of Pediatric Hypertension! Rasheda Amin, MD Division of Nephrology Pediatric Specialists of Virginia George Washington University
2 Disclosure I have no financial interests or relationships to disclose.
3 Objectives Pediatric HTN and Atherosclerosis Epidemiology Monitoring Definition Etiology Workup Management Complications Determine eligibility for participation in sports
4 Atherosclerosis Begins in Childhood
5 Cardiovascular Disease The Bogalusa Study: CVD risk factors in youth Autopsies in 204 young subjects (2-39y/o) fatty streaks in 50% & fibrous plaques in 20% (2-15 y/o) fatty streaks in 85% & fibrous plaques in 70% (21-39 y/o) Atherosclerotic changes were greater with increasing body mass index (BMI), blood pressure measurements, and levels of serum total cholesterol Risk factors for CVD tended to cluster. Berenson, NEJM, 1989
6 Prevalence of Hypertension in Children In the 1970s and1980s prevalence was 0.3% to 1.2% (Fixler, et al, Pediatrics 1979; Sinaiko et al, J Pediatr 1989) Now 5% of all children have HTN (Sorof et al, Pediatrics 2004) 3-24% of all children are pre-hypertensive Possibly due to growing population of obese children Obese children have 3X higher risk of HTN (Sorof & Daniels, Hypertension 2002) Are we underestimating prevalence?
7 Obesity Prevalence and Role in HTN Prevalence of obesity in 2-19 years olds remains high at 17% based on NHANES data. BP tables: 21% of this normative data comes from obese/ overweight children Obstructive sleep apnea common Dysfunctional adipocyte -> imbalance in expression of proand anti-inflammatory adipokines -> Hypertension Adipose Tissue Dysfunction: Macrophage infiltration Increased FFA Hyperleptinemia Adiponectin deficiency Increased resistin RAAS hormone secretion Mineralocorticoid stimulating factor RAAS Activation SNS Activation Oxidative stress and Inflammation Dorresteijn et al, Endothelial dysfunction Impaired pressure natriuresis Vascular hypertrophy
8 Current Guidelines The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents Published in Pediatrics, 2004
9 USPSTF Recommendations Evidence was insufficient to "assess the balance of benefits and harms of screening for primary hypertension in asymptomatic children and adolescents to prevent subsequent cardiovascular disease in childhood and adulthood (USPSTF 13) Immediate and strong reaction from ASPN and AHA issuing contradictory responses that continue to support routine BP measurement at well child visits
10 Monitoring of Blood Pressure When should blood pressure be measured Health maintenance visits ( 3y/o) Special populations < 3y/o premature/lbw neonates, or h/o CLD, Congenital HD, CKD, recurrent UTIs, transplant, malignancy, increased intracranial pressure, etc. Sports participation physicals Presentation with acute or chronic illness (if high, repeat when well)
11 Methods for BP Measurement Auscultation is the gold standard (since 1905) Normative data based on auscultation method Oscillometric (Dinamapp) device Measures mean arterial BP and then calculates systolic and diastolic values Any high reading should be confirmed by auscultation Appropriate for ICU - trends Yury et al, Circulation. 1996
12 Methods for BP Measurement Ambulatory BP monitoring (ABPM) portable device worn by the patient to record BP over a specific period (usually 24 hours) Masked or White coat HTN Wrist Blood Pressure Monitors Not validated or recommended for BP monitoring in children
13 Measurement of Blood Pressure Sitting quietly~5 minutes Pulse should be normal Child should be seated with back and feet supported Infants supine position Appropriate cuff size Right arm preferable Position of arm extended, heart level, supported by solid surface Inflate to 20-30mmHg > normal Deflation rate (2-3mmHg/heartbeat) K 1 = systolic BP K 5 (disappearance) = diastolic BP
14 Technique is Important!
15 Case Tim, a 10-year-old boy with a history of intermittent asthma and ADHD, is seeing you for a WCC. He has no complaints. ROS is negative. Current medications: Methylphenidate once daily and albuterol inhaler PRN. Family history: HTN- Father and paternal grandfather. PE: Height: 140 cm (50%), Weight: 45 kg (95%),BMI: 23 (>95%) Temp: 37 C, HR: 85 bpm, BP: 124/82mmHg (automated) Physical exam is normal
16 Case According to the BP tables published in the Fourth Report by the National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, the BP norms for a child of this age, gender, and height percentile are as follows: 50%: 102/61 90%: 116/76 95%: 120/80 99%: 127/88 124/82mmHg
17 BP Norms Gender, Age & Height
18 Definitions: Pediatric vs Adult
19 Severe Hypertension Hypertensive emergency: Severe symptomatic elevation in BP with evidence of potentially life threatening symptoms or acute target organ damage brain (seizures, increased intracranial pressure), eyes (papilledema, retinal hemorrhages, exudates), heart (heart failure), and kidneys (renal insufficiency). Hypertensive urgency: Severe elevation in BP without severe symptoms or evidence of acute target organ damage
20 BP Measurement Frequency Recommendations Frequency of BP Measurement Normal Prehypertension Stage 1 hypertension Stage 2 hypertension Recheck at next scheduled physical examination. Recheck in 6 months. Recheck in 1 2 weeks or sooner if the patient is symptomatic; if BP is persistently elevated on two additional occasions, evaluate or refer to source of care within 1 month. Evaluate or refer to source of care within 1 week or immediately if the patient is symptomatic.
21 Case Repeat Tim s BP by manual auscultation 126/84 mm Hg; one minute later it s 116/84 mm Hg; average BP of 121/84 BP is between 120/80 and 132/93 (the 95% and 99%+5 mm Hg) He is asymptomatic Have him return weekly on two more occasions. Manual BPs confirm he has sustained BPs 95% and < 99%+5 mm Hg Diagnosis: Stage 1 Hypertension
22 Etiology of HTN in Children Primary or Essential Hypertension Most common form of HTN and is a diagnosis of exclusion Common in all ages except infants More frequent in: African American children Family history of HTN Overweight or obese Secondary Hypertension For all age groups, renal parenchymal or renovascular causes together account for ~60-90% of secondary causes More frequent in: Younger children Children with a greater degree of BP increase at the time of initial diagnosis (Portman 2005, Brady 2009)
23 (Brady 2009) Age Based Etiology of HTN Age Etiology First year of life Secondary (99%) Coarctation of aorta, Renovascular, Renal parenchymal disease, Miscellaneous, Neoplasia, Endocrine years of age Secondary (70%-85%) Renal parenchymal disease, Coarctation of aorta, Reflux nephropathy, Renovascular, Neoplasia, Endocrine, Miscellaneous. Primary/ Essential (15%-30%) years of age Primary/ Essential (85%-95%) Secondary (5%-15%)
24 (Trachtman, 2014) Secondary Hypertension
25 Initial Workup of Hypertension History Physical Exam Laboratory studies Imaging Cardiac Studies Target Organ Damage
26 Clinical Assessment of a Child with Hypertension History Symptoms suggestive of endocrine etiology (weight loss, sweating, flushing) History of prematurity and/or placement of umbilical artery/vein catheter; neonatal course; birth weight History of UTI Symptoms of Obstructive Sleep Apnea Medications including steroids, decongestant/cold prep, OCP, stimulants, βadrenergic agonists, etc. Family history of HTN, early cardiovascular or cerebrovascular events, ESRD Diet (caffeine, salt intake) Smoking/drinking/recreational drugs Physical Activity
27 Clinical Assessment of a Child with Hypertension Important Physical Exam Elements Four extremity pulses and BP Moon facies, truncal obesity, buffalo hump Retinopathy Thyromegaly Skin lesions (café-au-lait spots, neurofibromas, adenoma sebaceum, striae, hirsutism, butterfly rash, purpura) Evidence of CHF Abdominal mass or bruits Edema Ambiguous genitilia in infants
28 Laboratory Studies Basic metabolic panel (electrolytes, BUN, HCO3, creatinine) Urinalysis, urine culture CBC to rule our anemia which could be consistent with CKD Fasting lipids and glucose Thyroid function tests Plasma renin activity and serum aldosterone level Drug screen (in high risk individuals)
29 Imaging, Cardiac & Other Tests Imaging: Renal ultrasound with Doppler examination of the renal vasculature Echocardiography including measurement of LVMI Renal arteriography: severe HTN or failure to control Other Tests: Retinal Exam: severe cases Assessment of catecholamines Polysomnography ABPM
30 Ambulatory BP Monitoring Target Population Suspected white-coat or masked HTN When other information on BP pattern is needed mean daily BP during the day, night and over 24 hours degree of nocturnal dipping BP load (%readings >95%) Correlates better than office BP with CV complications (e.g. LVH)
31 Diagnostic Algorithm for HTN Rodrigues-Cruz, 2011
32 Case Tim s Initial workup Normal electrolytes, renal function, thyroid and lipid profiles and urinalysis Normal renal Doppler ultrasound Echocardiography normal LVMI Normal retinal exam Diagnosis Primary HTN which is asymptomatic No evidence of end organ damage Management Lifestyle modifications
33 Who Needs Urgent Management? Symptomatic or acutely ill children should be immediately treated Severe, symptomatic hypertension should be treated with intravenous antihypertensive drugs Hydralazine Labetalol Nicardipine Nitroprusside Esmolol
34 Non-pharmacologic Management Aerobic exercise (30-45min) daily Weight reduction if indicated DASH (Dietary Approaches to Stop HTN) Diet Salt reduction (< g/d) Potassium and Calcium intake Cessation of smoking Yoga/meditation Physical activity with increased HR for minutes, 3-4x/wk can lead to a demonstrable drop in BP Loss of lbs is sufficient to achieve a meaningful reduction in BP (NHBEP 2004, Brady 2009,Trachtman 2011)
35 Pharmacologic Management The 2004 NHBPEP guidelines for pharmacological therapy Symptomatic HTN (e.g. headache, seizures, visual disturbances, etc) Stage 2 HTN Persistent Stage 1 HTN (without evidence of TOD) after a trial of 4-6 months of non-pharmacologic therapy Hypertensive target-organ damage, most often LVH Pre HTN or Stage 1 HTN with other risk factors / comorbidities such as dyslipidemia, CKD or DM Stage 1 HTN with family history of premature CVD
36 Class Examples Major Side Effects Comments Calcium Chanel Blockers Amlodipine Flushing, edema, headache, gingival hyperplasia Well tolerated Sports -ok ACE-I ARB Enalapril Lisinopril Losartan Cough, loss of taste, hyperkalemia angioedema Monitor K and RF Do not use in pregnancy/bl RAS Beta blockers Alpha & Beta blockers Atenolol Metoprolol Labetolol Bronchospasm, CHF, depression, masking of hypoglycemia, orthostasis Migraine Monitor HR Do not use in patients with CHF/ asthma/dm Diuretics HCTZ Furosemide Spironolactone Electrolyte abnorm, Hyperglycemia, nephrocalcinosis, gynaecomastia Care in athletes Monitor lytes Good adjuvants Central alpha agonists Clonidine Sedation, withdrawl Dry mouth Rebound HTN if stopped abruptly
37 Pharmacologic Therapy Choose an agent based on pathophysiology Begin with the lowest dose of an agent Titrate up to maximal dose as needed Add agents sequentially Aim for fewest medication side effects Aim for most patient compliance
38 Goal of Therapy Reduction of BP to <95th percentile, unless concurrent conditions are present. In that case, BP should be lowered to <90th percentile. Severe, symptomatic hypertension should be treated with intravenous antihypertensive drugs. Preventing end organ damage including vascular changes, cardiac damage and renal effects.
39 What are the Complications of Pediatric HTN? There is evidence that childhood HTN leads to adult HTN Target organ damage (TOD) Cardiovascular Left Ventricular Hypertrophy Prevalence of LVH in hypertensive children 25 to 70% No longitudinal studies in children Renal Proteinuria (No studies) Retinal Changes Neurocognitive
40 Left Ventricular Hypertrophy Echocardiographic assessment of left ventricular mass should be performed at diagnosis of hypertension and periodically thereafter. The presence of LVH is an indication to initiate or intensify antihypertensive therapy.
41 Elevated BP and Cognitive Function in Children & Adolescents NHANES III Data 6-16y 5077 children Prevalence SHTN 3.4%, DHTN 1.6% Groups: BP > or 90%ile Wechsler Intelligence Scale for Children, Wide Range Achievement Test, Revised Lande, 2003
42 Elevated BP and Cognitive Function in Children & Adolescents Lande, 2003
43 AAP: Sports Participation Athletes with significant hypertension may compete as long as no target organ damage or heart disease Office BP check needed for follow-up q 2 months With severe hypertension (uncontrolled stage 2), sports and highly static activities need to be restricted until BP well controlled Cardiovascular conditioning may continue Healthy lifestyle choices need to be encouraged Demorest et al. Pediatrics 2010
44 Sports Participation Dynamic Versus Static Exercise: Dynamic - intramuscular force not greatly increased; BP and MAP increases but dbp and tpr falls Static - large intramuscular forces but little change in muscle length or joint motion; sbp, MAP, dbp all rise significantly and tpr does not change
45 Classification of sports based on combined static and dynamic components MaxO2: maximal oxygen uptake MVC: Maximal voluntary contraction
46 HTN: New developments Updated guideline for the evaluation of elevated blood pressure in children and adolescents Sponsored by the American Academy of Pediatrics Multidisciplinary committee Increased CVD risk with pre-hypertension? Need for lower BP thresholds to decrease CVD risk? SHIP-AHOY The Population project -> investigate BP thresholds for development of hypertensive target organ damage (TOD) The Clinical Project -> characterize the ambulatory BP and metabolic phenotype best predicting TOD. The Basic Project -> investigate epigenetic changes that influence the development of TOD in youth with HTN.
47 The End Thank You!
48
Dr Doris M. W Kinuthia
Dr Doris M. W Kinuthia Objectives Normal blood pressures in children Measurement of blood pressure in children Aetiology of Hypertension in children Evaluation of children with hypertension Treatment of
More informationJared Moore, MD, FACP
Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner
More informationPediatric Hypertension. Alisa A. Acosta, MD, MPH Asst. Professor, Renal Section April 5, 2019
Pediatric Hypertension Alisa A. Acosta, MD, MPH Asst. Professor, Renal Section April 5, 2019 Objectives Recognize the importance of accurate blood pressure measurement in pediatric patients Define pediatric
More informationApproach to patient with hypertension. Dr. Amitesh Aggarwal
Approach to patient with hypertension Dr. Amitesh Aggarwal Definition A systolic blood pressure ( SBP) >139 mmhg and/or A diastolic (DBP) >89 mmhg. Based on the average of two or more properly measured,
More informationVA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005
VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,
More informationADVANCES IN MANAGEMENT OF HYPERTENSION
Advances in Management of Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Prevalence 29%; Blacks 33.5%
More informationManagement of Hypertension
Clinical Practice Guidelines Management of Hypertension Definition and classification of blood pressure levels (mmhg) Category Systolic Diastolic Normal
More informationDiabetes and Hypertension
Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for
More informationSystemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept
Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept Continents 1- introduction 2- classification/definition 3- classification/etiology 4-etiology in both categories 5- complications
More informationADVANCES IN MANAGEMENT OF HYPERTENSION
Prevalence 29%; Blacks 33.5% About 72.5% treated; 53.5% uncontrolled (>140/90) Risk for poor control: Latinos, Blacks, age 18-44 and 80,
More informationChronic Pediatric Hypertension
Chronic Pediatric Hypertension Nephrology Grand Round 3/13/2015 Mahmoud Kallash M.D Outline Definition of hypertension (HTN) Challenges in diagnosing HTN Epidemiology Causes and evaluation of HTN Management
More informationChildren with Hypertension in ED
Children with Hypertension in ED By Prof. Sanaa AK Helmy Professor of Anesthesia, Intensive Care and Pain Management, Faculty of Medicine, Cairo University Vice-chairman of the Egyptian Society of Emergency
More informationCreative blood pressure management: whys and the tricks
Creative blood pressure management: whys and the tricks Cynthia D. Caraballo-Hunt, MD Kaiser/OHSU Family Medicine Faculty Beaverton Medical Office NW Permanente, Portland, OR Objectives 1. Describe current
More information7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension
Prevalence of Hypertension Hypertension: Diagnosis and Management T. Villela, M.D. Program Director University of California, San Francisco-San Francisco General Hospital Family and Community Medicine
More informationPharmacologic Management of Hypertension
Current Concepts In Management of Fernando Vega, MD Secondary - Definition Renovascular Disease (The kidney doesn t get impressed by blood pressure) Renovascular stenosis Renal artery stenosis Fibromuscular
More informationRESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University
RESISTENT HYPERTENSION Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University Resistant Hypertension Blood pressure remaining above goal in spite of concurrent use of 3 antihypertensive
More informationHypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital
Hypertension Update 2008 Warwick Jaffe Interventional Cardiologist Ascot Hospital Definition of Hypertension Continuous variable At some point the risk becomes high enough to justify treatment Treatment
More informationManagement of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine
Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing
More information5.2 Key priorities for implementation
5.2 Key priorities for implementation From the full set of recommendations, the GDG selected ten key priorities for implementation. The criteria used for selecting these recommendations are listed in detail
More informationTIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN**
Documentation and coding guide Disease definitions* HTN is diagnosed when the average of two or more (systolic of diastolic) blood pressure readings are found to be elevated on two or more office visits
More informationhypertension Head of prevention and control of CVD disease office Ministry of heath
hypertension t. Samavat MD,Cadiologist,MPH Head of prevention and control of CVD disease office Ministry of heath RECOMMENDATIONS FOR HYPERTENSION DIAGNOSIS, ASSESSMENT, AND TREATMENT Definition of hypertension
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More informationPreventing and Treating High Blood Pressure
Preventing and Treating High Blood Pressure: Finding the Right Balance of Integrative and Pharmacologic Approaches Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Blood Pressure
More informationManaging Hypertension in 2016
Managing Hypertension in 2016: Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu
More informationModern Management of Hypertension
Modern Management of Hypertension Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Hypertension Prevalence
More informationCOMPLEX HYPERTENSION. Anita Ralstin, FNP-BC Next Step Health Consultant, LLC
COMPLEX HYPERTENSION Anita Ralstin, FNP-BC Next Step Health Consultant, LLC Incidence Of Hypertension About 70 million American adults have high blood pressure. About 33% of the population Only 52% have
More informationHypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy
Hypertension Update Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy Introduction 1/3 of US adults have HTN More prevalent in non-hispanic
More informationMANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION
Management of Hypertension: Treatment Thresholds and Medication Selection Robert B. Baron, MD MS Professor and Associate Dean Declaration of full disclosure: No conflict of interest Presentation Goals
More informationHypertension (JNC-8)
Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint
More informationHypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati
CHAPTER-I CARDIOVASCULAR SYSTEM Hypertension SUB: PHARMACOTHERAPEUTICS-I CODE:T0820006 Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati Hypertension
More informationUpdate in Hypertension
Update in Hypertension Eliseo J. PérezP rez-stable MD Professor of Medicine DGIM, Department of Medicine UCSF 20 May 2008 Declaration of full disclosure: No conflict of interest (I have never been funded
More informationMODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk
MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu
More informationHypertension Management Controversies in the Elderly Patient
Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No
More informationNew Hypertension Guideline Recommendations for Adults July 7, :45-9:30am
Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July
More informationCategories of HTN. Overview of Hypertension. Types of Hypertension
Categories of HTN Overview of Hypertension Normal SBP 100 Quick review of the Basics: What is
More informationEgyptian Hypertension Guidelines
Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich
More informationObjectives. JNC 7 Is Nice But What s Up With JNC 8? Why Do We Care? Hypertension Background: Prevalence
JNC 7 Is Nice But What s Up With JNC 8? 37 th Annual CAPA Conference October 4 th 2013 Ignacio de Artola, Jr. M.D. Assistant Professor of Clinical Family Medicine Medical Director, Primary Care Physician
More informationPresentation of hypertensive emergency
Presentation of hypertensive emergency Definitions surrounding hypertensive emergency Hypertension: elevated blood pressure (BP), usually defined as BP >140/90; pathological both in isolation and in association
More informationAdolescent Hypertension Roles of obesity and hyperuricemia. Daniel Landau, MD Pediatrics, Soroka University Medical Center
Adolescent Hypertension Roles of obesity and hyperuricemia Daniel Landau, MD Pediatrics, Soroka University Medical Center Blood Pressure Tables BP standards based on sex, age, and height provide a precise
More informationPEDIATRIC HYPERTENSION CLINICAL PRACTICE GUIDELINES. Milena Archuleta, MSN, MBA, FNP-BC, CPHON University of New Mexico Hospital
PEDIATRIC HYPERTENSION CLINICAL PRACTICE GUIDELINES Milena Archuleta, MSN, MBA, FNP-BC, CPHON University of New Mexico Hospital None Disclosures Hypertension: Why so Important? Occurs in 3.5% of all pediatric
More informationObesity and Hypertension. Manish Sinha Evelina London Children s Hospital
Obesity and Hypertension Manish Sinha Evelina London Children s Hospital Manchester 30 th June 2017 Scope of Talk Trends of childhood obesity in the UK Prevalence of hypertension in obese children Pathophysiology
More informationModern Management of Hypertension: Where Do We Draw the Line?
Modern Management of Hypertension: Where Do We Draw the Line? Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Blood Pressure
More informationNew Hypertension Guidelines. Kofi Osei, MD
New Hypertension Guidelines Kofi Osei, MD None Disclosures Objectives The new blood pressure definitions and cardiovascular risk The role to time and location in the diagnosis of hypertension Apply evidence-based
More informationYounger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.
Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.
More informationTodd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM
Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between
More informationGenetic factors. A number of genetic factors or interactions between genes play a major role in essential hypertension.
Hypertension Blood pressure is a measurement of the force against the walls of your arteries as your heart pumps blood through your body. Hypertension is another term used to describe high blood pressure.
More informationDr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None
Dr Narender Goel MD (Internal Medicine and Nephrology) drnarendergoel@gmail.com Financial Disclosure: None, Conflict of Interest: None 12 th December 2013, New York Visit us at: http://kidneyscience.info/
More informationDifficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair
Difficult-to-Control & Resistant Hypertension Anthony Viera, MD, MPH, FAHA Professor and Chair Objectives Define resistant hypertension Discuss evaluation strategy for patient with HTN that appears difficult
More informationAdult Blood Pressure Clinician Guide June 2018
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Adult Blood Pressure Clinician Guide June 2018 Adult Blood Pressure Clinician Guide June 2018 Introduction This Clinician Guide is based on the 2018
More informationTreating Hypertension from
Treating Hypertension from Initiation to Resistance: A Case Study Approach Michelle Krause, MD Division of Nephrology University of Arkansas for Medical Sciences Central Arkansas Veteran s Healthcare System
More informationObjectives. Describe results and implications of recent landmark hypertension trials
Hypertension Update Daniel Schwartz, MD Assistant Professor of Medicine Associate Medical Director of Heart Transplantation Temple University School of Medicine Disclosures I currently have no relationships
More informationIntroductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs
Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys
More informationWhat is hypertension?
HYPERTENSION What is hypertension? Abnormally elevated arterial blood pressure that is usually indicated by an adult systolic blood pressure of 140 mm Hg or greater or a diastolic blood pressure of 90
More informationBlood Pressure Treatment in 2018
Blood Pressure Treatment in 2018 Jay D. Geoghagan, MD, FACC Disclosures: None 1 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management
More informationHypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC
HypertensionTreatment Guidelines Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC Objectives: Review the definition of the different stages of HTN. Review the current guidelines for treatment of HTN. Provided
More information2017 AAP Guidelines for Childhood Hypertension
2017 AAP Guidelines for Childhood Hypertension Joseph T. Flynn, MD, MS, FAAP Professor of Pediatrics, University of Washington Chief, Division of Nephrology, Seattle Children s Hospital Disclaimer In the
More informationHypertension in the very old. Objectives: Clinical Perspective
Harvard Medical School Hypertension in the very old Ihab Hajjar, MD, MS, AGSF Associate Director, CV Research Lab Assistant Professor of Medicine, Harvard Medical School Objectives: Describe the clinical
More informationImportance of Ambulatory Blood Pressure Monitoring in Adolescents
Importance of Ambulatory Blood Pressure Monitoring in Adolescents Josep Redon, MD, PhD, FAHA Internal Medicine Hospital Clinico Universitario de Valencia University of Valencia CIBERObn Instituto de Salud
More informationBlood Pressure Measurement (children> 3 yrs)
Blood Pressure Measurement (children> 3 yrs) If initial BP elevated, repeat BP manually 2x and average, then classify Normal BP Systolic and diastolic
More informationHypertension Epidemiology 6% of deaths worldwide Defined as any of the following: systolic blood pressure 140 mmhg, diastolic blood pressure 90 mmhg, taking antihypertensive medications Pulse pressure=
More informationManagement of Hypertension. Ahmed El Hawary MD Suez Canal University
Management of Hypertension Ahmed El Hawary MD Suez Canal University Minimal vs. Optimal Care Resources more than science affect type of care and level of management. what is possible (minimal care) and
More informationGetting BP to goal: Virginia L. Hood MB.BS, MPH, FACP
Getting BP to goal: Virginia L. Hood MB.BS, MPH, FACP Objectives: Outline pathophysiological processes that sustain high BP Design individual treatment strategies for BP not at goal Facilitate patient
More informationDifficult to Treat Hypertension
Difficult to Treat Hypertension According to Goldilocks JNC 8 Blood Pressure Goals (2014) BP Goal 60 years old and greater*- systolic < 150 and diastolic < 90. (Grade A)** BP Goal 18-59 years old* diastolic
More informationManagement of High Blood Pressure in Adults
Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) James, P. A. (2014, February 05). 2014 Guideline for Management
More informationHypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)
Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More informationMPharmProgramme. Hypertension (HTN)
MPharmProgramme Hypertension (HTN) Slide 1 of 30 Overview Definition Prevalence Type Causes Diagnosis Management Patients perspective Slide 2 of 30 Definition It is not a disease! So what is it? What two
More informationHeart Failure Clinician Guide JANUARY 2018
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2018 Introduction This evidence-based guideline summary is based on the 2018 National Heart Failure Guideline.
More informationHypertension. Most important public health problem in developed countries
Hypertension Strategy for Continued Success in Treatment for the 21st Century November 15, 2005 Arnold B. Meshkov, M.D. Associate Professor of Medicine Temple University School of Medicine Philadelphia,
More informationAgenda. Management of Accelerated Hypertension (Updated in 2017) Salwa Roshdy Prof. of Cardiology Assiut University CardioEgypt 23/2/2017 2/27/2017
Management of Accelerated Hypertension (Updated in 2017) By Salwa Roshdy Prof. of Cardiology Assiut University CardioEgypt 23/2/2017 Agenda Definition of Accelerated HTN Pathophysiology & Etiology Prognosis
More information4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?
HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL
More informationChapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories
Chapter 23 Drugs for Hypertension Slide 37 Slide 41 Media Directory Nifedipine Animation Doxazosin Animation Upper Saddle River, New Jersey 07458 All rights reserved. Cardiovascular Disease (CVD) Includes
More informationHeart Failure Clinician Guide JANUARY 2016
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.
More informationHypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015
Hypertension Update Beverly J. Mathis, D.O. OOA May 2015 Objectives Learn new recommendations for BP treatment goals Approach to hypertension in the office Use of hypertensive drugs, and how to tailor
More informationHypertension in Pediatrics New Guidelines
Hypertension in Pediatrics New Guidelines MARISELIS ROSA-SAN CHEZ, M D PEDIATRIC NEPHROLOGY Disclosure Information In the past 12 months, I have had no relevant financial relationships with the manufacturer(s)
More informationHTN talk_l Davis_ /28/2018
1 2 GUIDELINES PUBLISHED AHEAD OF PRINT NOV 13, 2017 = SAME DAY AS PUBLIC PRESENTATION LESLIE L DAVIS, PHD, RN, ANP-BC, FPCNA, FAANP, FAHA The New Guidelines Have Been Published! Whelton PK, Carey RM,
More informationWhat s In the New Hypertension Guidelines?
American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the
More informationHypertension Update Background
Hypertension Update Background Overview Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Management Guideline Comparison
More informationMANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM
MANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM Are Particular Anti-hypertensives More Effective or Harmful Than Others in Hypertension in Pregnancy? Existing data is inadequate Methyldopa and
More informationHypertension Pharmacotherapy: A Practical Approach
Hypertension Pharmacotherapy: A Practical Approach Ronald Victor, MD Burns & Allen Chair in Cardiology Director, The Hypertension Center Associate Director, The Heart Institute Hypertension Center 1. 2.
More informationHypertension and the 2017 Guidelines Meeting the Targets in Small Groups. Lisa Ivy APRN
Hypertension and the 2017 Guidelines Meeting the Targets in Small Groups Lisa Ivy APRN The 2017 Guideline is an Update to JNC7 New information regarding BP related risk of CVD Ambulatory BP monitoring
More informationDr Diana R Holdright. MD, FRCP, FESC, FACC, MBBS, DA, BSc. Consultant Cardiologist HYPERTENSION.
Dr Diana R Holdright MD, FRCP, FESC, FACC, MBBS, DA, BSc. Consultant Cardiologist HYPERTENSION www.drholdright.co.uk Blood pressure is the pressure exerted on the walls of the arteries when the heart pumps;
More informationSecondary hypertension How to approach?
Secondary hypertension How to approach? Tomáš Seeman Department of Pediatrics and Transplantation Center, University Hospital Motol, 2 nd Faculty of Medicine, Charles University Prague, Czech Republic
More informationHypertension Update. Aaron J. Friedberg, MD
Hypertension Update Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Background Diagnosis Management Overview Guideline
More informationCONCORD INTERNAL MEDICINE HYPERTENSION PROTOCOL
CONCORD INTERNAL MEDICINE HYPERTENSION PROTOCOL Douglas G. Kelling Jr., MD Carmella Gismondi-Eagan, MD, FACP George C. Monroe, III, MD Revised, April 8, 2012 The information contained in this protocol
More informationBlood Pressure LIMBO How Low To Go?
Blood Pressure LIMBO How Low To Go? Joseph L. Kummer, MD, FACC Bryan Heart Spring Conference April 21 st, 2018 Hypertension Epidemiology Over a billion people have hypertension Major cause of morbidity
More informationThe Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children
More informationDISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE
ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE DISCLOSURES Editor-in-Chief- Nephrology- UpToDate- (Wolters Klewer) Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA 1 st Annual Internal
More informationFrom the desk of the: THE VIRTUAL NEPHROLOGIST
Hypertension, also referred to as high blood pressure or HTN, is a medical condition in which the blood pressure is chronically elevated. It is a very common illness. One out of three American adults has
More informationReframe the Paradigm of Hypertension treatment Focus on Diabetes
Reframe the Paradigm of Hypertension treatment Focus on Diabetes Paola Atallah, MD Lecturer of Clinical Medicine SGUMC EDL monthly meeting October 25,2016 Overview Physiopathology of hypertension Classification
More informationHypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg
Hypertension diagnosis (see detail document) Non-diabetic Diabetic Very elderly (older than 80 years) Target less than 140/90mmHg Target less than 130/80mmHg Consider SBP target less than 150mmHg Non-diabetic
More informationBlood Pressure. Michelle Bertram- Nephrology- OBH
Blood Pressure Michelle Bertram- Nephrology- OBH Hypertension- how common? 29-30% white adults 46-51% uncontrolled Diagnosis Two or more properly measured BP s after an initial screen NICE guidelines also
More informationINTRODUCTION TO RENAL SYSTYEM IN PEDIATRICS
INTRODUCTION TO RENAL SYSTYEM IN PEDIATRICS ANATOMY & PHYSIOLOGY OF KIDNEY Same as that of an adult but with few differences ; 1. Length approx. 6 cm and weight 24gm in a full term newborn as compared
More informationChildren s Mercy Hospitals and Clinics Evidence Based Practice Care Process Model
Children s Mercy Hospitals and Clinics Evidence Based Practice Care Process Model Care of the Inpatient > 1 year of age with Previously Undetected Hypertension Assessment and treatment for inpatients,
More information7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313)
University Pharmacy 5254 Anthony Wayne Drive Detroit, MI 48202 (313) 831-2008 Be able to identify the signs of a heart attack or stoke Identify what puts you at a higher risk for cardiovascular disease,
More informationIncidental Findings; Management of patients presenting with high BP. Phil Swales
Incidental Findings; Management of patients presenting with high BP Phil Swales Consultant Physician Acute & General Medicine University Hospitals of Leicester NHS Trust Objectives The approach to an incidental
More informationHypertension 2015: Recent Evidence that Will Change Your Practice
Hypertension 2015: Recent Evidence that Will Change Your Practice Gerald W. Smetana, M.D. Division of General Medicine Beth Israel Deaconess Medical Center Professor of Medicine Harvard Medical School
More information